- Home
- /
- Treatment
- /
- Page 157
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Eflornithine HCl | African trypanosomiasis | Hoechst Marion Roussel;P.O. Box 9627;Kansas City, Missouri, 64134 | April 23, 1986 | |
Eflornithine HCl | Pneumocystis carinii pneumonia in AIDS patients | Marion Merrell Dow, Inc.;P.O. Box 9627;Kansas City, Missouri, 64134 | April 18, 1986 | |
Epoetin alfa | Anemia associated with end stage renal disease | Amgen, Inc.;1840 Dehavilland Drive;Thousand Oaks, California, 91320 | April 10, 1986 | |
Diethyldithiocarbamate | AIDS | Connaught Laboratories;Route 611, P.O. Box 187;Swiftwater, Pennsylvania, 18370 | April 3, 1986 | |
Etidronate disodium | Hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration | MGI Pharma, Inc.;5775 West Old Shakopee Rd., Suite 100;Bloomington, Minnesota, 55437 | March 21, 1986 | |
Terlipressin | Bleeding esophageal varices | Ferring Pharmaceuticals Inc.;100 Interpace Parkway;Parsippany-Troy Hills, New Jersey, 07054 | March 6, 1986 | |
Potassium citrate and citric acid | For the dissolution and control of uric acid and cysteine calculi in the urinary tract | Willen Drug Company;; | February 14, 1986 | |
Beractant | Neonatal respiratory distress syndrome | Ross Laboratories;625 Cleveland Avenue;Columbus, OH, 43215 | February 5, 1986 | |
Beractant | Prevention of neonatal respiratory distress syndrome | Ross Laboratories;625 Cleveland Avenue;Columbus, OH, 43215 | February 5, 1986 | |
Beractant | Respiratory distress syndrome, infant | Ross Laboratories;625 Cleveland Avenue;Columbus, Ohio, 43215 | February 5, 1986 | |
Anti pan T lymphocyte monoclonal antibody | 1. For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts 2. For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease. | Xoma Corporation;2910 Seventh Street;Berkeley, California, 94710 | January 29, 1986 | |
Anti pan T lymphocyte monoclonal antibody | For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease | Xoma Corporation;2910 Seventh Street;Berkeley, CA, 94710 | January 29, 1986 | |
Anti pan T lymphocyte monoclonal antibody | For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts | Xoma Corporation;2910 Seventh Street;Berkeley, CA, 94710 | January 29, 1986 | |
Benzoate and phenylacetate | For adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency | ImmunexImmunex;2525 McGaw Avenue, P.O. Box 19791;Irvine, California, 92623 | January 21, 1986 | |
Tiopronin | Prevention of cystine nephrolithiasis in patients with homozygous cystinuria | Pak, Charles Y.C. M.D.;The University of Texas Health Scienc Center at Da, 5323 Harry Hines Boulevard;Dallas, Texas, 75235 | January 17, 1986 | |
Flunarizine | Alternating hemiplegia of childhood | Janssen Research Foundation;P.O. Box 200;Titusville, New Jersey, 08560 | January 6, 1986 | |
Flunarizine | Alternating hemiplegia | Janssen Research Foundation;P.O. Box 200;Titusville, NJ, 08560 | January 6, 1986 | |
Guanethidine monosulfate | Moderate to severe reflex sympathetic dystrophy and causalgia | Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 | January 6, 1986 | |
Antithrombin III human | Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition | American National Red Cross;9312 Old Georgetown Road;Bethesda, Maryland, 20814 | January 2, 1986 | |
Somatrem for injection | Short stature associated with Turner's syndrome | Genentech, Inc.;460 Point San Bruno Boulevard;South San Francisco, CA, 94080 | December 9, 1985 | |
Somatrem for injection | For long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion | Genentech, Inc.;460 Point San Bruno Boulevard;South San Francisco, CA, 94080 | December 9, 1985 | |
Colchicine | For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis | Pharmacontrol Corporation;661 Palisade Ave., P.O. Box 931;Englewood Cliffs, New Jersey, 07632 | December 9, 1985 | |
Rifampin | For antituberculosis treatment where use of the oral form of the drug is not feasible | Hoechst Marion Roussel;P.O. Box 9627;Kansas City, Missouri, 64134 | December 9, 1985 | |
Somatrem for injection | SHORT syndrome | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | December 9, 1985 | |
Allopurinol riboside | Chagas' disease | Burroughs Wellcome Company;3030 Cornwallis Road, P.O. Box 12700;Research Triangle Park, NC, 27709 | December 4, 1985 |